
First drug backed for NHS use in untreated Hodgkin lymphoma
Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated late-stage Hodgkin lymphoma.
Newsletters and Deep Dive digital magazine
Takeda's Adcetris has become the first drug recommended for routine NHS use as a treatment for previously untreated late-stage Hodgkin lymphoma.
If pharmaceuticals are included in President Trump's 'Liberation Day' tariffs, it is US consumers who will suffer the most, says a new report.
Prosecutors in the US are seeking the death penalty for Luigi Mangione in connection with the assassination of UnitedHealth CEO Brian Thompson.
Reduction in force (RIF) job losses have started in earnest at US federal agencies, including the FDA and CDC, according to media reports.
The UK has given a world-first approval to Rotop's RoTecPSMA, a new imaging agent for detecting lesions in men with prostate cancer.
Editor's Picks
Newsletters and Deep Dive
digital magazine